Literature DB >> 3536942

DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds.

G Eisenbrand, N Müller, E Denkel, W Sterzel.   

Abstract

Mechanisms of DNA adduct formation by antineoplastic 2-chloroethyl-N-nitrosoureas (CNUs) and of DNA damage induced by these compounds as well as by carcinogenic 2-hydroxyalkylnitrosamines are discussed. CNUs are monofunctional and bifunctional alkylating agents that form, in a quantitatively minor reaction, DNA-DNA crosslinks (XL). In vitro, by far the most abundant alkylation products of DNA are those resulting from 2-hydroxyethylation. The reaction sequence responsible for 2-hydroxyethylation comprises intermediate oxazolidine ring closure followed by generation of 2-hydroxyethylnitrosourea and ethylene oxide. Oxadiazolium intermediates have not been found to play a role. In contrast to the in vitro experiments, in vivo 2-hydroxyethyl adducts are formed to a much lesser extent und 2-chloroethyl adducts are predominant in rat kidney DNA. 2-Hydroxyethylation of phosphate groups introduces extreme instability into the sugar-phosphate backbone since the resulting phosphotriester rapidly breaks down through a dioxaphospholane ring intermediate. Measurements of DNA XL in target tumor tissue and in bone marrow provides a sensitive tool for evaluation in bone marrow provides a sensitive tool for evaluation of hormone-linked cytotoxic agents. The potent environmental carcinogen N-nitrosodiethanolamine (NDELA) has been found to be activated in the rat liver by a two-step metabolic transformation sequence involving alcohol dehydrogenase and, subsequently, sulfotransferase. Evidence for this mechanism is provided by measuring DNA single strand breaks in rat liver DNA and by studying the effect of various enzyme inhibitors on the extent of DNA damage induced in vivo by NDELA and its metabolites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536942     DOI: 10.1007/BF00395912

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

1.  Mechanism of action of the nitrosoureas--IV. Reactions of bis-chloroethyl nitrosourea and chloroethyl cyclohexyl nitrosourea with deoxyribonucleic acid.

Authors:  C T Gombar; W P Tong; D B Ludlum
Journal:  Biochem Pharmacol       Date:  1980-10-01       Impact factor: 5.858

2.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

3.  DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.

Authors:  P Bedford; G Eisenbrand
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

4.  Biological activity of N-nitrosodiethanolamine and of potential metabolites which may arise after activation by alcohol dehydrogenase in Salmonella typhimurium, in mammalian cells, and in vivo.

Authors:  E Denkel; B L Pool; J R Schlehofer; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  All oxygens in nucleic acids react with carcinogenic ethylating agents.

Authors:  B Singer
Journal:  Nature       Date:  1976-11-25       Impact factor: 49.962

6.  Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.

Authors:  G Eisenbrand; E Denkel; B Pool
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

7.  The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.

Authors:  P Bedford; M R Berger; G Eisenbrand; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Carcinogenicity of hydroxylated alkylnitrosoureas and of nitrosooxazolidones by mouse skin painting and by gavage in rats.

Authors:  W Lijinsky; M D Reuber
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

9.  The influence of N7 substituents on the stability of N7-alkylated guanosines.

Authors:  N Müller; G Eisenbrand
Journal:  Chem Biol Interact       Date:  1985 Feb-Apr       Impact factor: 5.192

10.  N-nitrosodiethanolamine is activated in the rat to an ultimate genotoxic metabolite by sulfotransferase.

Authors:  W Sterzel; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

View more
  7 in total

1.  Alleviation of 1,N6-ethanoadenine genotoxicity by the Escherichia coli adaptive response protein AlkB.

Authors:  Lauren E Frick; James C Delaney; Cintyu Wong; Catherine L Drennan; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

2.  Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining.

Authors:  Claire Chappell; Les A Hanakahi; Feridoun Karimi-Busheri; Michael Weinfeld; Stephen C West
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

3.  Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites.

Authors:  Daniel R McNeill; Wing Lam; Theodore L DeWeese; Yung-Chi Cheng; David M Wilson
Journal:  Mol Cancer Res       Date:  2009-05-26       Impact factor: 5.852

4.  Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine.

Authors:  Kevin P Rice; Edmund J Klinkerch; Scott A Gerber; Tyler R Schleicher; Tara J Kraus; Christopher M Buros
Journal:  Mol Cell Biochem       Date:  2012-08-05       Impact factor: 3.396

5.  Cytogenetic effects of N-nitrosodiethanolamine (NDELA) and NDELA-monoacetate in human lymphocytes.

Authors:  U Dittberner; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

6.  Inhibition of human DNA polymerase beta activity by the anticancer prodrug Cloretazine.

Authors:  Abbie M Frederick; Marguerite L Davis; Kevin P Rice
Journal:  Biochem Biophys Res Commun       Date:  2008-11-21       Impact factor: 3.575

7.  Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death.

Authors:  Weidong Ji; Mei Yang; Alexandra Praggastis; Yonghao Li; Huanjiao Jenny Zhou; Yun He; Roxanne Ghazvinian; Dylan J Cincotta; Kevin P Rice; Wang Min
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.